2m 2m 2m 2m 2m 2m 2m
PLIANT THERAPEUT (PLRX)
NASDAQ
$1.18+$0.005 (+0.43%)
Price as of Sep 11, 2026 7:30 PM EDT- $72.4MMarket Cap
- -26.42%1-Year Change
- BiotechnologyIndustry
PLIANT THERAPEUT (PLRX)
$1.18+$0.005 (+0.43%)
PLRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.17 | ||
Change | +$0.04 (+3.54%) | ||
Open | $1.14 | ||
High | $1.18 | ||
Low | $1.14 | ||
Previous Close | $1.13 | ||
Volume | 173,460 | ||
30-Day Average Volume | 465,803 | ||
1-Week Change | 0.86% | ||
1-Month Change | 13.59% | ||
1-Year Change | -26.42% | ||
3-Year Change | -92.87% | ||
5-Year Change | -93.69% | ||
Fundamentals | |||
Shares Outstanding | 61.9M | ||
Total Assets | $189.9M | ||
Market Cap | $72.4M | ||
Enterprise Value | $49.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$22.4M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$22.4M | ||
EBITDA | -$22.1M | ||
Net Working Capital | $146.7M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue